Sarah Pringle

Ellodi is developing a treatment of the eosinophilic esophagitis. 

TPG Capital will retain the rights to Adare's Eosinophilic Esophagitis (EoE) product, which has been spun out into a separate entity.

Today, the company has annual revenues in excess of €460 million ($540 million) and 850 employees.

MPE Partners will maintain a minority interest in the Trachte, which provides easy-deployment application-engineered protection and control buildings.

Odyssey previously weighed buying ProPharma through existing portfolio company TrialCard, three sources said.

If a deal is reached, existing investors Berkshire Partners and TPG Growth are expected to remain minority investors in the provider of outsourced pharma services.

The Thurston Group, a healthcare-focused PE firm based in Chicago, also invested in the deal.

The investment was made through Carlyle Partners VII, an $18.5 billion fund that makes majority and strategic minority investments primarily in the U.S. in targeted industries, including healthcare.

Demand for Health Advocate's employee wellness offerings is only accelerating in today’s environment as organizations start transitioning back to the workplace, sources said.

Five years into its investment, Wellspring will stay on as a minority investor in the provider of in-home care for seniors and individuals with disabilities.